Epidermal NAD+ deficiency induces IL-36–mediated skin inflammation and acanthosis
Nicotinamide adenine dinucleotide (NAD+) is essential for cellular metabolism, DNA repair, and stress responses. NAD+ is synthesized from nicotinamide, nicotinic acid (collectively termed niacin), and tryptophan. In humans, deficiencies in these nutrients result in pellagra, marked by dermatitis, diarrhea, and dementia. The dermatitis associated with pellagra typically manifests as photodermatosis in sun-exposed areas. This study examined the effects of NAD+ deficiency on skin homeostasis using epidermis-specific Nampt-conditional KO (Nampt-cKO) mice. These mice displayed substantial NAD+ depletion, reduced poly(ADP-ribose) polymerase (PARP) activity, and increased DNA damage. Consequently, Nampt-cKO mice developed spontaneous skin inflammation and epidermal hyperplasia. RNA-seq and IHC analyses demonstrated increased IL-36 cytokine expression, suggesting that DNA repair-related genomic stress triggers keratinocyte-driven IL-36 production, which promotes inflammation. Furthermore, reduced COL17A1 expression and elevated thymic stromal lymphopoietin (TSLP) levels were observed. NAD+ repletion by transdermal supplementation of nicotinamide mononucleotide (NMN) suppressed the rise of IL-36 levels and skin inflammation. These findings underscore the importance of Nampt-mediated NAD+ metabolism for epidermal stability and indicate that NAD+ depletion may contribute to IL-36-mediated skin inflammation, offering insights for therapeutic strategies in inflammatory skin disorders.
Authors
- Taiki Seki
- Mariam Karim
- Yasuhito Yahara (ORCID: https://orcid.org/0000-0001-9304-3728)
- Hiroko Uchida (ORCID: https://orcid.org/0000-0001-5372-5134)
- Jun-Dal Kim
- Keisuke Yaku
- Takashi Nakagawa
- Teruhiko Makino
- Tadamichi Shimizu
Institutions
- Japan Agency for Medical Research and Development (JP)
- Institute of Molecular Medicine (IN)
- University of Toyama (JP)
- Nagasaki University (JP)
Publication Details
- Journal
- JCI Insight
- Published
- 2026-02-10
- DOI
- https://doi.org/10.1172/jci.insight.189177
- Primary Topic
- Sirtuins and Resveratrol in Medicine
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Foundation for Applied Enzymology
- Takahashi Industrial and Economic Research Foundation
- Japan Agency for Medical Research and Development
- McDonnell Center for Systems Neuroscience
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
- Core Research for Evolutional Science and Technology
- Precursory Research for Embryonic Science and Technology